We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,315

A Look Inside Trump's 4-Point Plan For Curbing Drug Prices
  • Ropes & Gray LLP
  • USA
  • May 18 2018

On May 11, President Donald Trump outlined his administration’s four-point plan for curbing prescription drug prices. With rare exceptions, the plan


Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • May 14 2018

On Capitol Hill, reaction to President Donald Trump’s “American Patients First” plan to bring down prescription drug prices fell predictably along


FDA signals increasing focus on cybersecurity requirements
  • Hogan Lovells
  • USA
  • April 25 2018

With the continued explosion of software and software-controlled medical devices, including the growing use of machine learning and artificial


Federal Court Dismisses CFAA Claims Against Former Executive, Allows CFAA and DTSA Claims Against Competitor in Pharmaceuticals Trade Secret Dispute
  • Seyfarth Shaw LLP
  • USA
  • April 18 2018

A recent decision from the Eastern District of Pennsylvania reinforces the importance of the timing of purported misconduct in alleged violations of


Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • April 9 2018

Lawmakers return today to Capitol Hill after a two-week recess, and multiple committees in both the House and Senate are poised to examine the opioid


Healthcare: What’s in the 2018 Omnibus Appropriations Law?
  • Morgan Lewis & Bockius LLP
  • USA
  • March 30 2018

The recently passed omnibus appropriations bill includes extensive funding, often at higher amounts than in fiscal year 2017, for many US healthcare


Anticipating This Year's HIPAA Enforcement Trends
  • Jenner & Block LLP
  • USA
  • February 26 2018

We are a year into a new presidential administration, and yet it seems we are asking the same question that we were at this juncture last year: What


Washington Healthcare Update - Feb 19, 2018
  • McGuireWoods LLP
  • USA
  • February 19 2018

While the President’s budget is not likely to be acted upon by Congress, it does signal what the administration’s priorities areas well as what


Washington Healthcare Update - Feb 5, 2018
  • McGuireWoods LLP
  • USA
  • February 5 2018

The chairman of the House Appropriations Committee, Rodney Frelinghuysen, announced he will retire at the end of his term. The 12-term New Jersey


As Congress Struggles With ACA Repeal, Trump Administration Moves Forward With Regulatory Reform
  • Skadden Arps Slate Meagher & Flom LLP
  • USA
  • January 23 2018

The Trump administration and Republican-led Congress spent substantial time and political capital in 2017 on efforts to repeal and replace the